Zum Nutzen internationaler Standards bei der Vergabe von Genpatenten - Eine vergleichende Analyse am Beispiel der EU und Japans

Gilroy, Bernard Michael and Vollpert, Tobias (2003): Zum Nutzen internationaler Standards bei der Vergabe von Genpatenten - Eine vergleichende Analyse am Beispiel der EU und Japans.

Abstract

The specific characteristics of the R&D system of the modern molecular biotechnology lead to the fact that patent protection for genetic inventions cause almost simultaneously an useful information effect as well as a harmful blocking effect. Within this context, the present papers shows that the current attempts of the U.S., Japan, and the EU to establish consistent standards for patents in the area of genetic engineering, are only scarcely reasonable. Due to national distinctions of cultural and traditional conditions with view to the allocation and usage of property rights, an optimal patent system in Japan is not identical to one in Europe or the U.S.

• Item Type: MPRA Paper
• English Title: The benefits of international standards in the awarding of genetic patents - A comparative analysis between the EU and Japan
• Language: German
• Keywords: Patents; biotechnology; international harmonization
• Subjects: K - Law and Economics > K3 - Other Substantive Areas of Law > K33 - International Law; O - Economic Development, Innovation, Technological Change, and Growth > O3 - Innovation ; Research and Development ; Technological Change ; Intellectual Property Rights > O34 - Intellectual Property and Intellectual Capital; O - Economic Development, Innovation, Technological Change, and Growth > O3 - Innovation ; Research and Development ; Technological Change ; Intellectual Property Rights > O31 - Innovation and Invention: Processes and Incentives; K - Law and Economics > K1 - Basic Areas of Law > K11 - Property Law

References

Anthony Artuso, Drugs of Natural Origin: Economic and Policy Aspects of Discovery, Development, and Marketing. Pharmaceutical Product Press, New York, London, 1997.

James Bessen and Eric Maskin: Sequential innovation, patents, and imitation. Working Paper Nr. 00-01, Massachusetts Institute of Technology, Januar 2000.

Eric Antoon De Laat. Essays on Patent Policy: The Multi-dimensionality of Patents and Asymmetrie Information. Dissertation, Erasmus Universität Rotterdam, Januar 1997.

Ernst and Young: Beyond Borders: The global biotechnology report 2002. Ernst and Young, Cleveland, OH, 2002.

R. Gilbert and C. Shapiro: Optimal patent length and breadth. RAND Journal of Economics, 21:106-112, 1990.

B.M. Gilroy and T. Volpert: Economic insights and deficits in european biotechnology patent policy. Intereconomics, 37:150-155, 2002.

Angela Hullmann: Internationaler Wissenstransfer und technischer Wandel. Physica-Verlag, Heidelberg, 2001.

P. Klemperer: How broad should the scope of patent protection be? RAND Journal of Economics, 21:113-130, 1990.

OECD: Genetic Inventions, Intellectual Property Rights and Licensing Practices. OECD, Paris, 2002.

Jürgen Simon and Susanne Braun: Patentrecht und Biotechnologie: Patente auf Leben? Arbeitsbericht Nr. 261, Universität Lüneburg, Juni 2002.

Tilman Urs Spaethe: Die Pharmaindustrie und die Biotechnologie. Dissertation, page 256, 2001.

L.G. Zucker, M.R. Darby, and M.B. Brewer. Intellectual human capital and the birth of U.S. biotechnology enterprises. American Economic Review, 88:290-306, 1998.